Clinical Outcomes of Ablative MR-Guided Adaptive SBRT for Pancreatic Lesions
Ablative five‑fraction SMART is feasible, well tolerated and associated with encouraging early survival in pancreatic malignancies. The modest day‑to‑day tumor‑volume changes and low inter‑observer variation support the robustness of multi‑physician adaptive workflows.
Authors
- Sara Lim (ORCID: https://orcid.org/0000-0003-3281-1900)
- James J. Sohn (ORCID: https://orcid.org/0000-0001-7209-4104)
- Thomas Tarita
- Yirong Liu
Institutions
- Northwestern University (US)
- University of Chicago (US)
- Northwestern University (PH)
- City of Hope (US)
- Northwestern Medicine (US)
Publication Details
- Journal
- Pancreas
- Published
- 2026-03-27
- DOI
- https://doi.org/10.1097/mpa.0000000000002632
- Primary Topic
- Radiation Therapy and Dosimetry
- Type
- article
- Field-Weighted Citation Impact
- 0.00